Purchase Order 75D30126P20738
Award Date 1/16/26
Potential Completion Date 1/14/31
Potential Value $88K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $81,035.00 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Sebia, Inc., a global leader in automated electrophoresis technologies. The contract is for the provision of Capillarys DBS Instrument, which supports protein analysis, diagnostic testing, and clinical laboratory operations at the CDC's Pittsburgh facility. The contract has an ultimate completion date of September 30, 2024 and was awarded on September 4, 2024. Sebia,...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $33,840 firm fixed-price purchase order to Sebia, Inc., a global leader in automated electrophoresis technologies, to provide medical equipment, reagents, consumables, testing services, and maintenance support. This award is not set aside and is part of Sebia's broader contract vehicles with the Department of Veterans Affairs (VA) and Department of Defense (DoD) to deliver its specialized clinical laboratory technologies....
- This is a $82,225 firm fixed-price purchase order contract awarded to Sebia, Inc., a global leader in automated electrophoresis technologies, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract is for the provision of CAPILLARYS 3 OCTA diagnostic equipment, which enables protein analysis and clinical testing services for federal healthcare agencies. This award is not associated with a set-aside program. Sebia, Inc. holds several significant federal contract...
- This is a firm fixed-price delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to Sebia, Inc., a for-profit medical diagnostics company based in Norcross, Georgia. The contract, valued at $72,850.00, is for the procurement of a Sebia Capillarys 3 OCTA instrument to support blood analysis requirements. The contract is not set aside and is placed under the Critical Analyzers, Laboratory...
- The Centers for Disease Control and Prevention (CDC) awarded an $82,263 firm fixed price purchase order to Sedia Biosciences Corporation for laboratory supplies and equipment to support rapid recency kits. Sedia Biosciences, doing business as Sedia Biosciences Corp., will deliver the requested supplies and equipment from its location in Chamblee, Georgia to support CDC programs in Pittsburgh, Pennsylvania by December 30, 2023. No subcontractors or set aside designations were identified. The...
- The Centers for Disease Control and Prevention (CDC) awarded a $43,908.76 firm fixed price purchase order to Cepheid for laboratory equipment maintenance services. The contract will support CDC's mission through its Pittsburgh location and involves maintaining equipment to support its disease control and prevention efforts. Cepheid will perform the maintenance work in Atlanta, Georgia over a one year base period of performance from July 2023 through July 2024. No subcontractors or set aside...
- Sebia, Inc. received a $5,039.86 firm fixed-price Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs' Veterans Integrated Service Network 8 (VISN 8) on October 1, 2024, for short-term electrophoresis equipment and services with a completion deadline of September 30, 2025. The award was made without a set-aside designation, reflecting Sebia's competitive position in the federal marketplace. The contract is rooted in Sebia's broader $32 million Federal Supply Schedule...
- The U.S. government agency Medical Command awarded a $444,009.20 firm fixed price purchase order contract to Sebia, Inc., a global leader in automated electrophoresis technologies. The contract is for CAPILLARYS HEMOGLOBIN and does not have a set-aside designation. Sebia, Inc. provides advanced medical diagnostic equipment, reagents, consumables, and clinical testing services to federal healthcare agencies. The contract has an ultimate completion date of September 30, 2017. Sebia, Inc. holds...
- This is a federal contract award to Sebia, Inc., a global leader in automated electrophoresis technologies, for the provision of laboratory reagents to the Defense Health Agency. The contract, with a ceiling value of $24,578.89, is a Blanket Purchase Agreement (BPA) call placed under an existing Indefinite Delivery Vehicle (IDV) and has a firm fixed-price pricing type. The contract has an ultimate completion date of September 30, 2025. Sebia, Inc. is a for-profit organization based in...
- Sebia, Inc. was awarded a $160,042.33 firm fixed-price delivery order by Veterans Integrated Service Network 23 (VISN 23) on October 1, 2024, for clinical analyzers and reagents. This non-set-aside contract, which runs through September 30, 2025, will be performed in Norcross, Georgia, where Sebia maintains its headquarters. The award represents a delivery order drawn from one of Sebia's existing indefinite delivery vehicles with the Department of Veterans Affairs, leveraging the company's...